Based on the broad genotype-dependent chromatin accessibility at AD risk variants in stimulated CD4+ T cells, our data support allelic transcriptional regulation as an important epigenetic mechanism mediating disease risk in AD. The gene discussed is CD4; the disease is Alzheimer disease.